Monday - October 07, 2024

Hidradenitis Suppurativa Clinical Trials 2024: FDA Approvals, Pipeline, Medication, Therapies, Mechanism of Action, Route of Administration and Companies by DelveInsight

Hidradenitis Suppurativa Clinical Trials Hidradenitis Suppurativa companies are Kymera Therapeutics, Novartis, Incyte Corporation, Pfizer, Lytix Biopharma, Aclaris Therapeutics, AbbVie, Azora Therapeutics, InflaRx, UCB, ChemoCentryx, Amgen, Eli Lilly, Janssen Biotech, Boehringer Ingelheim, CSL Behring, and others. (Albany, United States) As per … Continue reading